CCN3: Doctor Jekyll and mister Hyde

Journal of Cell Communication and Signaling

Volumn 2, Issue 1-2, 2008, Pages 3-7

  Perbal, Bernard ^a  

^a L'Oreal USA   (United States)

Author keywords

Angiogenesis; Anti proliferative; ccn proteins; ccn1; ccn2; ccn3; novH; Prognosis; Pronostic; Signaling; Tumor suppressor; VEGF

Indexed keywords

BIOLOGICAL MARKER; GROWTH FACTOR; IMATINIB; PROTEIN CCN2; PROTEIN CCN3; PROTEIN MRD4; REGULATOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; GROWTH DISORDER; HUMAN; KIDNEY CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; PROTEIN BLOOD LEVEL; PROTEIN ENGINEERING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

ORYCTOLAGUS CUNICULUS;

EID: 54949137641     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-008-0028-0     Document Type: Article

References (25)

1. Benini S, Perbal B, Zambelli D, Colombo MP, Manara MC, Serra M, Parenza M, Martinez V, Picci P, Scotlandi K (2005) In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type. Oncogene 24(27):4349-4361 (Jun 23)
2. Bleau AM, Planque N, Lazar N, Zambelli D, Ori A, Quan T et al (2007) Antiproliferative activity of CCN3: Involvement of the C-terminal module and post-translational regulation. J Cell Biochem 101:1475-1491 doi: 10.1002/jcb.21262
3. Chevalier G, Yeger H, Martinerie C, Laurent M, Alami J, Schofield PN, Perbal B (1998) novH: Differential expression in developing kidney and Wilm's tumors. Am J Pathol 152(6):1563-1575 (Jun)
4. Fukunaga-Kalabis M, Martinez G, Liu ZJ, Kalabis J, Mrass P, Weninger W et al (2006) CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1. J Cell Biol 175:563-569 doi: 10.1083/ jcb.200602132
5. Glukhova L, Angevin E, Lavialle C, Cadot B, Terrier-Lacombe MJ, Perbal B, Bernheim A, Goguel AF (2001) Patterns of specific genomic alterations associated with poor prognosis in high-grade renal cell carcinomas. Cancer Genet Cytogenet 130(2):105-110 (Oct 15)
6. Gupta N, Wang H, McLeod TL, Naus CC, Kyurkchiev S, Advani S, Yu J, Perbal B, Weichselbaum RR (2001) Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol 54(5):293-299 (Oct)
7. Holbourn K, Acharya R, Perbal B (2008) The CCN family of proteins: structure functions relationships. Trends Biochem Sci (in press)
8. Joliot V, Martinerie C, Dambrine G, Plassiart G, Brisac M, Crochet J et al (1992) Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol 12:10-21
9. Katsuki Y, Sakamoto K, Minamizato T, Makino H, Umezawa A, Ikeda MA, Perbal B, Amagasa T, Yamaguchi A, Katsube K (2008) Inhibitory effect of CT domain of CCN3/NOV on proliferation and differentiation of osteogenic mesenchymal stem cells, Kusa-A1. Biochem Biophys Res Commun 368:808-814 (Epub Feb 12)
10. Leask A, Abraham DJ (2006) All in the CCN family: Essential matricellular signaling modulators emerge from the bunker. J Cell Sci 119:4803-4810 doi: 10.1242/jcs.03270
11. Lin CG, Leu SJ, Chen N, Tebeau CM, Lin SX, Yeung CY et al (2003) CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem 278:24200-24208 doi: 10.1074/jbc.M302028200
12. Liu C, Liu XJ, Crowe PD, Kelner GS, Fan J, Barry G, Manu F, Ling N, De Souza EB, Maki RA (1999) Nephroblastoma overexpressed gene (NOV) codes for a growth factor that induces protein tyrosine phosphorylation. Gene 238(2):471-478 (Oct 1)
13. Maillard M, Cadot B, Ball RY, Sethia K, Edwards DR, Perbal B, Tatoud R (2001) Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues. Mol Pathol 54(4):275-280 (Aug)
14. Manara MC, Perbal B, Benini S, Strammiello R, Cerisano V, Perdichizzi S, Serra M, Astolfi A, Bertoni F, Alami J, Yeger H, Picci P, Scotlandi K (2002) The expression of ccn3(nov) gene in musculoskeletal tumors. Am J Pathol 160(3):849-859 (Mar)
15. McCallum L, Price S, Planque N, Perbal B, Pierce A, Whetton AD et al (2006) A novel mechanism for BCR-ABL action: Stimulated secretion of CCN3 is involved in growth and differentiation regulation. Blood 108(5):1716-1723, (Sep 1, Epub 2006 May 2)
16. Perbal B (1994) Contribution of MAV-1-induced nephroblastoma to the study of genes involved in human Wilms' tumor development. Crit Rev Oncog 5(6):589-613
17. Perbal B (1999) Nuclear localisation of NOVH protein: A potential role for NOV in the regulation of gene expression. Mol Pathol 52(2):84-91 (Apr)
18. Perbal B (2001) NOV (nephroblastoma overexpressed) and the CCN family of genes: Structural and functional issues. Mol Pathol 54:57-79 doi: 10.1136/mp.54.2.57
19. Perbal B (2004) CCN proteins: Multifunctional signalling regulators. Lancet 363:62-64
20. Perbal B (2006a) NOV story: The way to CCN3. Cell Commun Signal 4:3 doi: 10.1186/1478-811X-4-3
21. Perbal B (2006b) New insight into CCN3 interactions - nuclear CCN3: Fact or fantasy? Cell Commun Signal 4:6 (Aug 8)
22. Perbal B, Takigawa M (2005) CCN Proteins: A new family of cell growth and differentiation regulators (1st edn). Imperial College Press, London
23. Perbal B, Zuntini M, Zambelli D, Serra M, Sciandra M, Cantiani L, Lucarelli E, Picci P, Scotlandi K (2008) Prognostic value of CCN3 in osteosarcoma. Clin Cancer Res 14(3):701-709 (Feb 1)
24. Planque N, Long Li C, Saule S, Bleau AM, Perbal B (2006) Nuclear addressing provides a clue for the transforming activity of amino-truncated CCN3 proteins. J Cell Biochem 99(1):105-116 (Sep 1)
25. Vallacchi V, Daniotti M, Ratti F, Di Stasi D, Deho P, De Filippo A, Tragni G, Balsari A, Carbone A, Rivoltini L, Parmiani G, Lazar N, Perbal B, Rodolfo M (2008) CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma. Cancer Res 68(3):715-723 (Feb 1, Erratum in Cancer Res. 2008 Mar 15;68(6):2051)